Juno Therapeutics

BiotechnologySeries BSeattle, USjunotherapeutics.com

Latest round

Series B

Last raised

Aug 2014

Total raised

$310M

Investors

4

About Juno Therapeutics

Juno Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, specializing in developing innovative cell therapies for cancer treatment.Founded in 2013, Juno Therapeutics is dedicated to the research and development of cell-based immunotherapies specifically for cancer. The company was founded by Michael Jensen and has undergone strategic pivots since inception.Juno Therapeutics develops leading-edge cell therapies targeting cancer treatments. These therapies aim to harness the immune system's capability to fight cancer, focusing on various types of blood cancers.14 mn for the same year. The company is looking to expand its market presence, targeting new geographical regions by 2025 to make its therapies accessible to a wider patient population.

Who invested in Juno Therapeutics

4 investors across 4 rounds

See all investors in Juno Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 5, 2014

    Amount

    $134M

    Investors

    Locked

  2. Series A

    Apr 24, 2014

    Amount

    $31M

    Investors

    Locked

  3. Series A

    Jan 13, 2014

    Amount

    $25M

    Investors

    Locked

  4. Series A

    Dec 4, 2013

    Amount

    $120M

    Investors

    Locked

Questions about Juno Therapeutics

Who invested in Juno Therapeutics?

Juno Therapeutics has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Juno Therapeutics raised?

Juno Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Juno Therapeutics last raise money?

Juno Therapeutics's most recent round on record is a Series B, in Aug 2014.

What does Juno Therapeutics do?

Juno Therapeutics is a biotechnology company.

Where is Juno Therapeutics headquartered?

Juno Therapeutics is headquartered in Seattle, US.

Which VCs invest in companies like Juno Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Juno Therapeutics's stage. Their profiles are linked below.

Raising like Juno Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.